Theravance Biopharma (TBPH) Will Present Significant TD-5108 Phase 2 Data at DDW 2015
Tweet Send to a Friend
Theravance Biopharma (NASDAQ: TBPH) announced the presentation of positive data from a Phase 2 study of velusetrag (TD-5108), an investigational ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
